Drawing for MONTAVIT

USPTO serial 79143569

MONTAVIT

Reviewed by CopyMark Law Group

Reg. 4639073Status 404
Filing date
Status date
Registration date
Nov 18, 2014
Examiner
SINGH, TEJBIR
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MONTAVIT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebeccah Gan

Rebeccah Gan WENDEROTH LLP1030 15th Street, NW Suite 400 EastWashington, D.C., DC 20005UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Allergy medications; Antiallergic medicines; Medicines for intestinal disorders; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for use in dermatology; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations acting on the central nervous system; Pharmaceuticals, namely, antihelmintics and antihistamines; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for treating alimentary tract and canal diseases and illnesses; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; All-purpose disinfectants; Urinary tract disinfectants; Disinfectants for sanitary purposes; Dietetic foodstuffs in the nature of vitamin supplements, vitamins and vitamin preparations, mineral food supplements, mineral supplements, mineral nutritional supplements, vitamin and mineral preparations for medical use, dietary and nutritional supplements and nutraceuticals for use as a dietary supplement; Medicated supplements for foodstuffs for animals; Medicated supplements for foodstuffs for babiesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 2, 2023DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Dec 2, 2023DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 11, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jun 8, 2022XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jun 8, 2022XXCRGENERIC MADRID TRANSACTION CREATED—
Feb 25, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 4, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jun 4, 2021C71TCANCELLED SECTION 71—
Nov 18, 2019REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Sep 4, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 4, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 22, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 16, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 16, 2015FIMPFINAL DISPOSITION PROCESSED—
Feb 18, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 18, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 2, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 29, 2014GPNXNOTIFICATION PROCESSED BY IB—
Aug 13, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 13, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 13, 2014NPUBNOTICE OF PUBLICATION—
Jul 31, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 30, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 30, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Jul 30, 2014CNEAEXAMINERS AMENDMENT MAILED—
Jul 30, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 29, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 29, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 23, 2014ALIEASSIGNED TO LIE—
Jul 18, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 17, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 17, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 8, 2014RFNTREFUSAL PROCESSED BY IB—
Apr 23, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 23, 2014RFRRREFUSAL PROCESSED BY MPU—
Apr 23, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 22, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2014DOCKASSIGNED TO EXAMINER—
Mar 12, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 8, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 7, 2014LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Mar 6, 2014SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance